BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the immune status in a female population sample 10 years after rubella vaccination]. 1985

A Becchi, and M Fornero, and G Mantovani

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Becchi, and M Fornero, and G Mantovani
[Immune status of a school-population sample 5 years after antirubella vaccination].
January 1982, Giornale di batteriologia, virologia ed immunologia,
A Becchi, and M Fornero, and G Mantovani
[Anti-rubella vaccination. I. Preliminary results of a trial of anti-rubella vaccination in a sample of the female population].
January 1973, Annali Sclavo; rivista di microbiologia e di immunologia,
A Becchi, and M Fornero, and G Mantovani
[Evaluation of the specific immune response after anti-rubella vaccination].
January 1988, Quaderni Sclavo di diagnostica clinica e di laboratorio,
A Becchi, and M Fornero, and G Mantovani
Rubella immune state and rubella vaccination of female university students.
January 1984, Scandinavian journal of infectious diseases,
A Becchi, and M Fornero, and G Mantovani
[Immune status for poliomyelitis, rubella and measles of the Dutch population 10 years or older in 1980; a serological study].
October 1984, Nederlands tijdschrift voor geneeskunde,
A Becchi, and M Fornero, and G Mantovani
[Sero-epidemiological studies of the anti-rubella immunological status of a sample of the female population].
January 1980, Giornale di batteriologia, virologia ed immunologia,
A Becchi, and M Fornero, and G Mantovani
The rubella immune status of female hospital personnel.
January 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A Becchi, and M Fornero, and G Mantovani
[Rubella immunity 5 years after vaccination].
April 1978, La Nouvelle presse medicale,
A Becchi, and M Fornero, and G Mantovani
Rubella vaccination: persistence of antibodies for 10-21 years.
October 1988, Lancet (London, England),
A Becchi, and M Fornero, and G Mantovani
[Population impact of rotavirus vaccination in Mexico after 10 years].
January 2020, Salud publica de Mexico,
Copied contents to your clipboard!